42 cos banned over supply of substandard drugs

Jaipur:  The Rajasthan Medical Services Corporation (RMSC) Wednesday issued orders banning 42 pharma companies from supplying drugs as the samples were found to be substandard under the state govt’s free medicine scheme.

Companies whose products failed the quality tests will be prohibited from participating in tenders.

RMSC managing director Neha Giri said, “This is an important step towards ensuring the quality and timely supply of medicines. We have banned 32 firms for one year, eight firms for two years, and two firms for three years due to their products failing the tests.”

According to the corporation’s quality policy, every batch of supplied medicine undergoes quality testing in an approved lab, and only those that pass are distributed to hospitals. These drugs were initially found substandard in preliminary tests, and upon confirmation, actions were taken against the respective supplier companies.

Giri said that the management of purchase and supply of medicines in the chief minister free medicine scheme is being further strengthened. Along with this, special focus is also being laid on the quality of medicines. Besides, more drugs were found to be substandard.

Related Posts

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

Three arrested after liquor bottles found at pharma firm

Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources